Acute Kidney Injury (Medicine) Flashcards
Treatment of Hyperkalaemia
- Salbutamol Nebulisers
- 10u Actrapid in 50mls 50% Dextrose
- 500ml 1.26% NaHCO3 over 1 hour
- 10 ml of 10% of Calcium gluconate (only if ECG changes)
Measurement of Kidney Function
- Creatinine
- eGRF
- Urine Output
Scale of AKI problem
- AKI is common (10-20% hospitalised patients)
- a/w harm (need dialysis, peventable iatrogenic, 40% don’t survive)
- costly
- development of AKI is modifiable
Why do patients die of AKI in hospital?
- Delay in recognition of AKI in post-admission patients
- Poor assessments of risk factors of AKI
- Poor management of AKI
- Missed complications of AKI
Causes of AKI
Pre-renal (reduced renal perfusion)
- Hypotension
- Hepatorenal syndrome
- Renal Artery Stenosis
- Renal Artery clot
Renal
- Drugs (NSAIDS, ACEi, ARBs, Gentamicin)
- GN/Vasculitis
- Contrast
- Interstitial nephritis
- Myeloma
- Rhabdomyolisis
Post-renal (obstruction)
- prostate enlargement
- renal stones
- pelvic cancer
Percentage of AKI that is hospital acquired or Community acquired, and causes respectively.
Hospital acquired (50.3%) - Renal causes (Drugs)
Community acquired (49.7%) - Pre-renal causes
Big Risk Factor for AKI
Chronic Kidney Disease (CKD)
>50%
AKI Prevention
The risk of AKI is contributed to by the acute insult and background morbidity.
What are the acute insult and background morbidity?
Background morbidity
- Elderly
- CKD
- Cardiac failure
- Liver disease
- Diabetes
- Vascular disease
- Background nephrotoxic medications
Acute insult - Acute STOP Sepsis & Hypoperfusion Toxicity Obstruction Parenchymal Kidney Disease
What are STOP aki?
Sepsis & Hypoperfusion
- Severe sepsis
- haemorrhage
- Dehydration
- Cardiac failure
- Liver Failure
- Renovascular insults
Toxicity
- Nephrotoxic drugs
- Iodinated Radiological Contrast
Obstruction
- Bladder outflow
- Stones
- Tumour
- Surgical ligation of ureters
- Extrinsic compression (e.g lymph nodes)
- Retroperitoneal fibrosis
Parenchymal Kidney Disease
- GN
- TIN
- Rhabdomyolysis
- HUS
- Myeloma kidney
- Malignant Hypertension
Prevent AKI - The 4 M’s
- Monitor the patients
- Obs & EWS
- Regular fluids
- Maintain fluid charts
- assess urinary output and daily weights - Maintain circulation
- fluid resuscitation
- oxygenation - Minimise Kidney Insult
- Avoid NSAID’s Gentamycin, iodinated contrast - Manage Acute Illness
- recognise and treat sepsis promptly
- diuretics for hypervolaemia in heart failure. (not to maintain urine output)
What kind of things do you need to consider if one of your patients has CKD?
- Increased risk for AKI
- medication handling (if someone is anuric, their eGFR is 0ml/min, regardless of creatinine)
Recognising AKI early:
The AKI network Classification
Stage 1
Increase in serum creatinine >150-200% from baseline
Urinary output (UO) less than 0.5 ml/kg per h for >6 h
Stage 2
Increase in serum creatinine > 200-300%
UO less than 0.5 ml/kg per h for >12 h
Stage 3
Increase in serum creatinine >300%
UO less than 0.3 ml\kg for 24 h or anuria for 12 h
Recognising AKI early:
AKI identification
- Identify AKI (serum creatinine > 1.5 x basline) and presume normal baseline if no previous results available.
- clarify whether Dx likely to be pre-renal, renal or post-renal causes (can co-exist)
- Immune symptoms
rash, new arthritis, nasal crusting/bleeding, haemoptysis, new deafness, mouth ulcers, alopecia, iritis/episcleritis, mononeuritis multiplex or neuropathy - Obstructive symptoms/signs
poor stream, hesitancy, frequency, nocturia, PV bleeding, stones
Recognising AKI early:
AKI Examination
- Fluid status, BP, JVP, loin tenderness, palpable bladder, rash, oedema, signs of autoimmune disease
- Urine dipstick Must be done in all: AKI Non-dialysis CKD DVT or PE Oedematous patients Suspected UTI
- Everyone gets US Kidney to check size and outrule obstruction.
Dipstick results (Blood only) - differentials (4)
Trauma
Malignancy
Stones
Rhabdomyolysis
Dipstick results (Blood & protein) (4)
GN
Vasculitis
UTI
Malignant Hypertension
Dipstick Results (Protein only) (4)
GN
Amyloid
Severe HTN
Diabetic nephropathy
Dipstick Results (-ve for blood and proteins)
Pre-renal or post-renal
Interstitial nephritis
Drugs
Myeloma - cast nephropathy
Dipstick results (shows leucocyte or nitrites) What should you do?
Send MSU
Dipstick results ( shows protein on Dipstick) What should you do?
Send urine protein creatinine ratio
Management of AKI, the 4 M’s (same as prevention)
- Monitor the patients
- Obs & EWS
- Regular bloods - daily or twice daily (U/E, TCO2, CPM, FBC)
- Maintain fluid charts
- assess urinary output (+/- catheter) and daily weights - Maintain circulation
- fluid resuscitation
- oxygenation - Minimise Kidney Insult
- Avoid NSAID’s Gentamycin, iodinated contrast - Manage Acute Illness
- recognise and treat sepsis promptly
- diuretics for hypervolaemia in heart failure. (not to maintain urine output)
- stop metformin if eGFT <30ml/min or creatinine rising
- Suspect vasculitis or pulmonary renal syndromes
- Follow contrast nephropathy guidelines when imaging with IV contrast is done
- Avoid gadolinium based dye for MR scans if eGFR < 30ml/min
What to consider in contrast nephropathy?
- Assess Risk
- High volume (>100ml) iodinated contrast procedure & CKD with eGFR <60 (particularly diabetic nephropathy) or AKI
- other risk factors (STOP) - Is contrast procedure necessary?
- Resuscitate to euvolemia
- Give Prophylaxis if high risk of AKI
- Volume expansion (unless hypervolaemic) with normal saline or 1.26% bicarbonate - minimise contrast, use low or iso-osmolar contrast
- Monitor function to 72 hours in high risk
- if oliguria or rising creatinine, early referral to renal team - Hold diuretics/ACEi/ ARB/ NSAIDs on the day
What is the potassium level to be considered as hyperkalemia?
K > 5.5
Management of Hyperkalemia due to AKI?
- Eliminate dietary sources
- Stop offending meds (diuretics, trimethoprim)
Immunology Screen for AKI
Criteria
- Age > 40
- Haematuria
- Proteinuria
- Others
Immunology Screen for AKI
Age >40
SPEP and UPEP (myeloma screen)
Immunology Screen for AKI
Haematuria
ANCA ANA C3 C4 HBV HCV
Immunology Screen for AKI
Proteinuria
HIV ANA C3 C4 HBV HCV
Immunology Screen for AKI
Others
Cryo if rash
ENAs if ANA +ve
anti-GBM if rapidly declining renal function/ haematuria/ lung pathology
Between AKi and long term renal & CV outcomes, which one is more worrisome?
AKI
- greater risk for death (hazard ratio 1.85)
- MAKE defined as a need for long-term dialysis, a 25% decline in eGFR or death